79 results on '"Kosaka, Takeo"'
Search Results
2. Fatal Intracranial Hemorrhage Due to Thrombocytopenia in a Patient With Castration-Resistant Prostate Cancer Showing Extensive Bone Uptake of Injected 223Ra Dichloride
3. A novel oncoplastic technique for breast cancer localized in the lower pole of the breast
4. Determining When to Stop Prostate Specific Antigen Monitoring after Radical Prostatectomy: the Role of Ultrasensitive Prostate Specific Antigen
5. Novel algorithm for management of acute epididymitis
6. Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters
7. Continuous use of enzalutamide in a patient who developed enzalutamide-induced thrombocytopenia
8. A NEW STRATEGY FOR THE TREATMENT OF PROSTATE CANCER BY TARGETING VASOHIBIN-2: MP90-09
9. REACTIVE OXYGEN SPECIES INDUCTION BY CABAZITAXEL VIA INHIBITION OF THE SESTRIN FAMILY IN CASTRATION-RESISTANT PROSTATE CANCER: MP90-03
10. BIOINFORMATIC ANALYSIS UTILIZING THE ANDROGENIC SUPPRESSIVE EFFECT IDENTIFIED PROMISING CANDIDATE DRUGS FOR REPROGRAMMING DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER: MP84-20
11. CD44V8-10 INVOLVES ACQUISITION OF CISPLATIN-RESISTANCE IN UROTHELIAL CANCER: MP83-10
12. ARE THERE ANY APPROPRIATE CRITERIA FOR RECOMMENDING PROSTATE BIOPSY IN PATIENTS OVER 75 YEARS OLD?: MP39-20
13. LONG-TERM FOLLOW-UP DATA AFTER RADICAL PROSTATECTOMY: DETERMINING WHEN TO STOP PSA MONITORING: MP40-07
14. IMPACT OF MAXIMUM TUMOR DIAMETER ADJUSTED BY PRIMARY TUMOR LOCATION IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA MANAGED BY RADICAL NEPHROURETERECTOMY: THE MULTI-INSTITUTIONAL STUDY: MP27-18
15. PROGNOSTIC ROLE OF PROGRAMMED CELL DEATH PROTEIN 1 EXPRESSION IN SURGICALLY TREATED PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA.: MP27-02
16. EXTERNAL VALIDATION OF PROGNOSTIC IMPACT OF PATIENT AGE AND GENDER IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY: PROPOSED NEW PERSPECTIVE OF GENDER-ADJUSTED AGE IN UPPER TRACT UROTHELIAL CARCINOMA: PD13-12
17. A NOVEL PATHOLOGY RELATED TO SUBCAPSULAR ALDOSTERONE-PRODUCING CELL CLUSTERS CAUSES HYPERALDOSTERONISM: MP12-11
18. Placebo-Induced Severe Diarrhea in a Patient With Metastatic Castration-Resistant Prostate Cancer Participating in a Double-Blind, Randomized, Phase III International Trial
19. Spontaneous Regression of Epstein-Barr Virus-Positive Primary Diffuse Large Cell B-Cell Lymphoma of the Urinary Bladder After the Cessation of Enzalutamide
20. Erectile function status is highly associated with prostate-specific antigen bounce in localized prostate cancer patients treated with permanent prostate brachytherapy
21. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism
22. Ureteral metastasis from prostate cancer
23. Renin–angiotensin system blockade: Its contribution and controversy
24. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke
25. MP49-03 RELATIONSHIP BETWEEN INCREASED EXPRESSION OF AXL-GAS6 SIGNAL CASCADE AND PROGNOSIS IN UPPER URINARY TRACT UROTHELIAL CARCINOMA.
26. MP35-20 PLASMA FIBRINOGEN LEVEL INDEPENDENTLY PREDICTS THE PROGNOSIS OF PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA
27. PD17-03 “TUMOR BUDDING”, A NOVEL PROGNOSTIC INDICATOR FOR PREDICTING STAGE PROGRESSION IN T1 BLADDER TUMORS
28. MP7-10 THE PROGNOSTIC IMPACT OF HISTONE H3K27 TRIMETHYLATION REGULATED BY EZH2 IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
29. Impact of an Adjuvant Chemotherapeutic Regimen on the Clinical Outcome in High Risk Patients with Upper Tract Urothelial Carcinoma: A Japanese Multi-Institution Experience
30. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas
31. Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model
32. Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer
33. Prognostic value of preoperative multiparametric magnetic resonance imaging (MRI) for predicting biochemical recurrence after radical prostatectomy
34. PROSPECTIVE EVALUATION OF EFFICACY AND SAFETY OF SOLIFENACIN AND MIRABEGRON TREATMENT IN BPH PATIENTS TREATED WITH DUTASTERIDE BUT HAVING OAB SYMPTOMS: PD23-11
35. POST-TRANSLATIONAL MODIFICATION MEDIATED BY THE PROLYL ISOMERASE PIN1 ACCERELATE CANCER PROGRESSION IN CASTRATION RESISTANT PROSTATE CANCER: MP52-20
36. METFORMIN IS A NEW THERAPEUTIC STRATEGY FOR TARGETING CD44 VARIANT IN BLADDER CANCER: MP39-14
37. NICOTINE INDUCES TUMOR AGGRESSIVENESS AND CHEMORESISTANCE THROUGH ACTIVATION OF PI3K/AKT/MTOR PATHWAY IN BLADDER CANCER: MP34-01
38. PROGNOSTIC SIGNIFICANCE OF TNF-α AND CD44 EXPRESSION IN CLEAR CELL RENAL CELL CARCINOMAS: IMPLICATION OF CANCER INVASION, METASTASIS, AND RESISTANCE TO SUNITINIB TREATMENT: MP29-05
39. INCREASED EXPRESSION OF ARYL HYDROCARBON RECEPTOR IN CLEAR CELL RENAL CELL CARCINOMA AND INFILTRATING LYMPHOCYTES: IMPLICATIONS FOR CANCER INVASION, PROGNOSIS AND TUMOR IMMUNITY: MP29-02
40. AXL IS A NOVEL PROGNOSTIC MARKER IN UPPER URINARY TRACT UROTHELIAL CARCINOM: MP28-04
41. METABOLIC SHIFT UNDER HYPOXIC ENVIRONMENT CAUSES RESISTANCE TO MTOR INHIBITOR IN HUMAN CASTRATION RESISTANT PROSTATE CANCER.: MP24-14
42. DRUG EFFICACY REPROGRAMMING BY RIBAVIRIN AGAINST THE CANCER STEMNESS IN DOCETAXEL-RESISTANT PROSTATE CANCER: MP24-10
43. THERAPEUTIC EFFECT BY TARGETING BCL-XL PROTEIN IN UROTHELIAL CARCINOMA CELLS: MP21-13
44. UP-REGULATED NFκB ACTIVATION IS A POTENT THERAPEUTIC TARGET IN ACQUIRED PLATINUM-RESISTANT BLADDER CANCER: THE EFFICACY OF NFκB BLOCKADE BY DEHYDROXYMETHYL DERIVATIVE OF EPOXYQUINOMICIN (DHMEQ): MP21-11
45. DEVELOPMENT OF AN ALGORITHM FOR PREDICTING SEVERE ACUTE EPIDIDYMITIS: MP16-18
46. Dual PI3K/mTOR Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer
47. Three ileus cases associated with the use of dipeptidyl peptidase-4 inhibitors in diabetic patients
48. Editorial Comment to Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison
49. Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming
50. Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.